Recurrent Disease After Curative Pancreatic Resection for Patients with Non-Functional Neuroendocrine Tumor; Identify the High Risk Patient

#1050

Introduction: Since the overall favourable survival, detection of recurrent disease is one of the main goals during follow up in patients with resected pancreatic neuroendocrine tumors (pNET).

Aim(s): The aim of this study was to analyse the risk for recurrent disease in an selective group of patients with non-functional pNET (NF-pNET).

Materials and methods: Retrospectively all resected NF-pNET from 1997-2013 of two academic institutions were included. Patients with distant metastases or hereditary syndromes were excluded. Pathology is revised according WHO classification 2010. Primary outcome was recurrent disease. Recurrent disease was defined as local tumor recurrence in the pancreas, localization in lymph nodes or distant metastases. An nomogram was made to predict recurrent disease within 5 year after curative resection.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Jilesen A

Authors: Jilesen A, Van Eijck C, Van Kemenade F, Van Eeden S, Verheij J,

Keywords: NF,